Bank Of America Corp Ocugen, Inc. Put Options Transaction History

Bank Of America Corp

  • $1.12 Trillion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 08, 2022
BUY
$4.38 - $15.67 $908,850 - $3.25 Million
207,500 Added 914.1%
230,200 $1.05 Million
Q3 2021

Nov 15, 2021
SELL
$6.36 - $8.51 $16.3 Million - $21.8 Million
-2,563,900 Reduced 99.12%
22,700 $163,000
Q2 2021

Sep 13, 2021
BUY
$5.52 - $15.68 $14.3 Million - $40.6 Million
2,586,600 New
2,586,600 $20.8 Million

Others Institutions Holding OCGN

# of Institutions
110
Shares Held
66.8M
Call Options Held
516K
Put Options Held
272K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $232M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email